Discontinuation of antidepressant medication in primary care whether or not supported by Mindfulness Based Cognitive Therapy (MBCT).

Discontinuation of antidepressant medication in primary care whether or not supported by Mindfulness Based Cognitive Therapy (MBCT). - Discontinuation of antidepressant medication in primary care.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON42862

Enrollment

138

Registered

2016-09-12

Start date

2017-02-20

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety depression

Interventions

General practices offer either SPD or SPD+MBCT -Supported Protocolized Discontinuation (SPD) Patient and GP make a shared decision whether to continue of discontinue the antidepressant medication. Th

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Having received prescriptions for antidepressants in primary care for at least nine months.

Exclusion criteria

Exclusion criteria: 1. Current treatment by a psychiatrist; 2. Current diagnosis of substance use disorder; 3. Non-psychiatric indication for long-term antidepressant usage (i.e. neuropathic pain); 4. Inability to perform the necessary assessment due to an understanding of the Dutch language; 5. Cognitive impairments; 6. Younger than 18 years.

Design outcomes

Primary

Measure	Time frame
Primary outcome is the proportion of patients successfully discontinuing antidepressant medication at 6 months (end of treatment).	—

Secondary

Measure	Time frame
Secondary outcome measures will be the adverse and discontinuation effects, symptoms of depression and anxiety, psychological well-being, quality of life and medical and societal costs.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)